lutein has been researched along with Lung Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, XL; Hu, F; Lu, YY; Pan, MJ; Su, Y; Wei, XS; Yang, WB; Zhang, SY; Zhou, Q | 1 |
| Baraya, YS; Wong, KK; Yaacob, NS; Yankuzo, HM | 1 |
| Gurunathan, S; Jeyaraj, M; Kang, MH; Kim, JH | 1 |
| Brusselle, GG; Franco, OH; Hofman, A; Kiefte-de Jong, JC; Lahousse, L; Leermakers, ET; Melo van Lent, D; Stricker, BH | 1 |
| Galanko, JA; Littman, A; Satia, JA; Slatore, CG; White, E | 1 |
| Svennevig, K | 1 |
| Ando, M; Ito, Y; Kondo, T; Nishino, Y; Ohno, Y; Ozasa, K; Seki, N; Suzuki, K; Tamakoshi, A; Wakai, K; Watanabe, Y | 1 |
| Cohen, SY | 1 |
| Heber, D | 1 |
| Colditz, GA; Feskanich, D; Giovannucci, E; Michaud, DS; Rimm, EB; Speizer, FE; Willett, WC | 1 |
1 review(s) available for lutein and Lung Neoplasms
| Article | Year |
|---|---|
[Vitamins for prevention of age related macular degeneration: efficacy and risk].
Topics: Aged; beta Carotene; Causality; Comorbidity; Dietary Supplements; Humans; Lung Neoplasms; Lutein; Macular Degeneration; Middle Aged; Risk Assessment; Smoking; Vitamins; Xanthophylls; Zeaxanthins | 2006 |
1 trial(s) available for lutein and Lung Neoplasms
| Article | Year |
|---|---|
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Topics: Aged; beta Carotene; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Double-Blind Method; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Humans; Incidence; Lung Neoplasms; Lutein; Macular Degeneration; Male; Middle Aged; Risk; Treatment Outcome; Vitamins; Xanthophylls; Zeaxanthins; Zinc | 2013 |
10 other study(ies) available for lutein and Lung Neoplasms
| Article | Year |
|---|---|
Lutein inhibits tumor progression through the ATR/Chk1/p53 signaling pathway in non-small cell lung cancer.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Lung Neoplasms; Lutein; Mice; Signal Transduction; Tumor Suppressor Protein p53 | 2023 |
Strobilanthes crispus bioactive subfraction inhibits tumor progression and improves hematological and morphological parameters in mouse mammary carcinoma model.
Topics: Acanthaceae; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Female; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lutein; Mice, Inbred BALB C; Plant Extracts; Sitosterols; Splenic Neoplasms; Tumor Burden | 2021 |
Platinum Nanoparticles Enhance Exosome Release in Human Lung Epithelial Adenocarcinoma Cancer Cells (A549): Oxidative Stress and the Ceramide Pathway are Key Players.
Topics: A549 Cells; Acetylcholinesterase; Acetylcysteine; Adenocarcinoma of Lung; Aniline Compounds; Benzylidene Compounds; Cell Proliferation; Cell Survival; Ceramides; Enzyme Activation; Exosomes; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Lutein; Metal Nanoparticles; Neoplasm Proteins; Oxidative Stress; Particle Size; Platinum; RNA, Messenger; Serum; Sphingomyelin Phosphodiesterase; Static Electricity | 2021 |
Association between lutein intake and lung function in adults: the Rotterdam Study.
Topics: Aged; Antioxidants; Body Mass Index; Cohort Studies; Cross-Sectional Studies; Diet; Female; Forced Expiratory Volume; Humans; Lung; Lung Neoplasms; Lutein; Male; Middle Aged; Netherlands; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Risk Factors; Smoking; Vital Capacity | 2017 |
Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study.
Topics: Aged; beta Carotene; Carotenoids; Dietary Supplements; Female; Humans; Lung Neoplasms; Lutein; Lycopene; Male; Middle Aged; Risk Factors; Smoking; Surveys and Questionnaires; Vitamin A; Vitamins | 2009 |
Re: "Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins and Lifestyle (VITAL) Study".
Topics: Antioxidants; beta Carotene; Carotenoids; Evidence-Based Medicine; Humans; Life Style; Lung Neoplasms; Lutein; Lycopene; Risk; Vitamin A; Vitamins | 2009 |
Serum carotenoids and mortality from lung cancer: a case-control study nested in the Japan Collaborative Cohort (JACC) study.
Topics: Adult; Aged; Alcohol Drinking; Anticarcinogenic Agents; Antioxidants; beta Carotene; Body Mass Index; Canthaxanthin; Carotenoids; Case-Control Studies; Cholesterol; Cohort Studies; Cryptoxanthins; Feeding Behavior; Female; Folic Acid; Follow-Up Studies; Humans; Japan; Life Style; Lung Neoplasms; Lutein; Lycopene; Male; Middle Aged; Odds Ratio; Smoking; Tocopherols; Vitamin A; Xanthophylls | 2003 |
Lutein and zeaxanthin. Monograph.
Topics: beta Carotene; Cardiovascular Diseases; Cataract; Humans; Lung Neoplasms; Lutein; Macular Degeneration; Radiodermatitis; Retinitis Pigmentosa; Xanthophylls; Zeaxanthins | 2005 |
Colorful cancer prevention: alpha-carotene, lycopene, and lung cancer.
Topics: Carotenoids; Edible Grain; Feeding Behavior; Folic Acid; Fruit; Humans; Lung Neoplasms; Lutein; Lycopene; Nutrition Policy; Smoking; Vegetables | 2000 |
Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts.
Topics: Adult; Aged; beta Carotene; Carotenoids; Cohort Studies; Cryptoxanthins; Eating; Female; Humans; Linear Models; Lung Neoplasms; Lutein; Lycopene; Male; Middle Aged; Prospective Studies; Regression Analysis; Risk Factors; Smoking; Surveys and Questionnaires; Xanthophylls | 2000 |